1. Home
  2. AENT vs NMRA Comparison

AENT vs NMRA Comparison

Compare AENT & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliance Entertainment Holding Corporation

AENT

Alliance Entertainment Holding Corporation

N/A

Current Price

$6.58

Market Cap

261.4M

ML Signal

N/A

NMRA

Neumora Therapeutics Inc.

HOLD

Current Price

$2.12

Market Cap

554.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AENT
NMRA
Founded
1990
2019
Country
United States
United States
Employees
697
N/A
Industry
Durable Goods
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
261.4M
554.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
AENT
NMRA
Price
$6.58
$2.12
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$10.00
$6.57
AVG Volume (30 Days)
27.8K
1.1M
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.23
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.44
N/A
Revenue Next Year
$1.64
N/A
P/E Ratio
$11.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$0.63
52 Week High
$8.80
$3.65

Technical Indicators

Market Signals
Indicator
AENT
NMRA
Relative Strength Index (RSI) 54.18 35.52
Support Level $6.81 $2.10
Resistance Level $7.46 $2.20
Average True Range (ATR) 0.53 0.17
MACD -0.03 -0.07
Stochastic Oscillator 52.74 27.78

Price Performance

Historical Comparison
AENT
NMRA

About AENT Alliance Entertainment Holding Corporation

Alliance Entertainment Holding Corp is a distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world. The company has two divisions: Alliance Home Entertainment, which offers full-service support across production, marketing, and retail execution. and Alliance Authentic, which focuses on licensed collectibles and branded merchandise, including partnerships with Handmade by Robots, Master Replicas, and Weta Workshop.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: